Interpace Biosciences, Inc. Share Price
Stocks
IDXG.D
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
OTC Markets
01:23:58 29/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 7.618 USD | +5.08% |
|
+0.05% | +23.85% |
| Market Cap | 4.22Cr 3.64Cr 3.41Cr 3.11Cr 5.86Cr 403.37Cr 5.88Cr 40Cr 16Cr 203.62Cr 16Cr 16Cr 675.17Cr | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 4.09Cr 3.52Cr 3.3Cr 3.02Cr 5.68Cr 390.74Cr 5.7Cr 39Cr 15Cr 197.24Cr 15Cr 15Cr 654.02Cr | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.08% | ||
| 1 week | +0.05% | ||
| Current month | +0.44% | ||
| 1 month | -1.86% | ||
| 3 months | -15.36% | ||
| 6 months | -14.60% | ||
| Current year | +23.85% |
| 1 week | 6.5 |  | 7.85 |
| 1 month | 6.5 | | 8.5 |
| Current year | 5.15 | | 12 |
| 1 year | 3.85 | | 12 |
| 3 years | 2.22 | | 17.7 |
| 5 years | 2.22 | | 51.65 |
| 10 years | 2.22 | | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/08/26 | Free | Director | 69,252 | 0.2501% | ||
| 20/08/26 | Fiscal year | Chief Financial Officer | 13,85,045 | 5.0015% | ||
| 20/08/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.08% | +0.05% | +84.68% | +49.37% | 4.22Cr | |
| -3.67% | -1.74% | +94.34% | +487.75% | 4.7TCr | |
| -0.21% | -0.37% | +21.73% | +57.89% | 2.72TCr | |
| -0.30% | -4.93% | -16.15% | -37.78% | 710.47Cr | |
| -1.00% | -2.88% | +3.93% | +134.99% | 587.16Cr | |
| -0.27% | +1.95% | +16.22% | +76.62% | 337.55Cr | |
| -3.26% | -0.84% | -33.07% | +1,921.90% | 257.47Cr | |
| -3.17% | +6.30% | +150.35% | +30.70% | 231.9Cr | |
| +1.02% | +1.02% | +29.25% | +25.80% | 196.96Cr | |
| -1.93% | -12.54% | -14.69% | -54.48% | 188.8Cr | |
| Average | -0.77% | -0.92% | +33.66% | +269.28% | 993.51Cr | |
| Weighted average by Cap. | -2.06% | -1.38% | +53.22% | +304.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.69Cr 4.04Cr 3.79Cr 3.46Cr 6.52Cr 448.49Cr 6.54Cr 45Cr 18Cr 226.4Cr 18Cr 17Cr 750.69Cr | 3.87Cr 3.34Cr 3.13Cr 2.86Cr 5.38Cr 370.14Cr 5.4Cr 37Cr 14Cr 186.84Cr 15Cr 14Cr 619.54Cr |
| Net income | 67.02L 57.75L 54.15L 49.43L 93.12L 64Cr 93.41L 6.42Cr 2.51Cr 32Cr 2.52Cr 2.46Cr 107.21Cr | 2.46Cr 2.12Cr 1.99Cr 1.81Cr 3.41Cr 234.87Cr 3.43Cr 24Cr 9.19Cr 118.56Cr 9.23Cr 9.03Cr 393.13Cr |
| Net Debt | 43.95L 37.87L 35.51L 32.41L 61.06L 42Cr 61.26L 4.21Cr 1.64Cr 21Cr 1.65Cr 1.61Cr 70Cr | -13.22L -11.39L -10.68L -10L -18.37L -13Cr -18.43L -1.27Cr -49.44L -6.38Cr -49.63L -48.55L -21Cr |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $7.618 | +5.08% | 2,520 |
| 26/26/26 | $7.250 | +2.11% | 1,420 |
| 25/26/25 | $7.100 | -0.70% | 1,299 |
| 24/26/24 | $7.150 | -6.09% | 402 |
| 21/26/21 | $7.614 | -5.42% | 1,965 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG.D Stock
Select your edition
All financial news and data tailored to specific country editions
